Delivery Order SPE2DB20D1100-SPE2DB24FD7G7
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Entecavir 0.5 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award, valued at $3,422.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets and has a performance period through January 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $9,458.03 firm fixed-price delivery order is for the supply of 4,565,749,496 tablets of the medication Entecavir 0.5 mg. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Entecavir 0.5 mg tablets. The $2,211.77 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,933.51, is for the delivery of 30-count tablets of the medication Entecavir 0.5 mg. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $9,022.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. This is a firm-fixed-price delivery order contract with a completion date of September 30, 2024. The contract does not have a set-aside designation. As a large pharmaceutical distributor,...
This federal contract award is for the delivery of Entecavir 0.5 mg tablets in quantities of 30 to the Defense Logistics Agency (DLA). The award, valued at $2,026.88, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of June 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,737,205 units of the drug Entecavir 0.5 mg tablets. The $1,801.35 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of December 17, 2024. The award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the supply of Entecavir 0.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order, valued at $2,131.53, was issued under the $999,999,999 DLA Troop Support Medical Indefinite Delivery Contract that runs through December 2025. This contract vehicle enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies to...